Sunitinib in Metastatic Renal Cancer

NCT01034878 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

DRUG: Sunitinib

Sponsor

Istituto Clinico Humanitas